NO20016404D0 - Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse - Google Patents
Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disseInfo
- Publication number
- NO20016404D0 NO20016404D0 NO20016404A NO20016404A NO20016404D0 NO 20016404 D0 NO20016404 D0 NO 20016404D0 NO 20016404 A NO20016404 A NO 20016404A NO 20016404 A NO20016404 A NO 20016404A NO 20016404 D0 NO20016404 D0 NO 20016404D0
- Authority
- NO
- Norway
- Prior art keywords
- processes
- preparation
- pharmaceutical compositions
- naphthyridine derivatives
- naphthyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99112636A EP1065207A1 (en) | 1999-07-02 | 1999-07-02 | Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them |
PCT/EP2000/005920 WO2001002398A1 (en) | 1999-07-02 | 2000-06-26 | Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20016404D0 true NO20016404D0 (no) | 2001-12-28 |
NO20016404L NO20016404L (no) | 2002-03-01 |
Family
ID=8238482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20016404A NO20016404L (no) | 1999-07-02 | 2001-12-28 | Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse |
Country Status (33)
Country | Link |
---|---|
US (2) | US6743800B1 (no) |
EP (2) | EP1065207A1 (no) |
JP (1) | JP2003503496A (no) |
KR (1) | KR20020015996A (no) |
CN (1) | CN1160356C (no) |
AR (1) | AR024622A1 (no) |
AT (1) | ATE305471T1 (no) |
AU (1) | AU775386B2 (no) |
BG (1) | BG106257A (no) |
BR (1) | BR0012129A (no) |
CA (1) | CA2376668C (no) |
CZ (1) | CZ20014605A3 (no) |
DE (2) | DE60022890T4 (no) |
DK (1) | DK1210348T3 (no) |
EA (1) | EA004369B1 (no) |
EE (1) | EE200100711A (no) |
ES (1) | ES2250157T3 (no) |
HK (1) | HK1050003B (no) |
HR (1) | HRP20010946A2 (no) |
HU (1) | HUP0203539A3 (no) |
IL (1) | IL147248A0 (no) |
MX (1) | MXPA01013435A (no) |
MY (1) | MY133246A (no) |
NO (1) | NO20016404L (no) |
NZ (1) | NZ516058A (no) |
PL (1) | PL352280A1 (no) |
SK (1) | SK19132001A3 (no) |
TR (1) | TR200103856T2 (no) |
TW (1) | TW593319B (no) |
UA (1) | UA73133C2 (no) |
WO (1) | WO2001002398A1 (no) |
YU (1) | YU92201A (no) |
ZA (1) | ZA200200016B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1065207A1 (en) * | 1999-07-02 | 2001-01-03 | Aventis Pharma Deutschland GmbH | Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them |
DE10042655A1 (de) * | 2000-08-31 | 2002-03-14 | Aventis Pharma Gmbh | Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion |
FR2847254B1 (fr) | 2002-11-19 | 2005-01-28 | Aventis Pharma Sa | Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant |
JP4866610B2 (ja) * | 2003-08-18 | 2012-02-01 | 富士フイルムファインケミカルズ株式会社 | ピリジルテトラヒドロピリジン類およびピリジルピペリジン類 |
FR2870541B1 (fr) | 2004-05-18 | 2006-07-14 | Proskelia Sas | Derives de pyrimidines antigonistes du recepteur de la vitronectine |
US20110237605A1 (en) * | 2010-03-26 | 2011-09-29 | Eric Phillips | Molecular Crystal of (4-(1,8-Naphthyridin-2-YL)Piperidin-1-YL)Pyrimidine Derivative |
CN107312039B (zh) | 2012-08-30 | 2019-06-25 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药的制备方法 |
HUE063437T2 (hu) | 2013-09-24 | 2024-01-28 | Fujifilm Corp | Nitrogént tartalmazó vegyületet vagy sóját vagy fémkomplexét tartalmazó gyógyászati készítmény |
AU2021267373A1 (en) | 2020-05-06 | 2022-12-08 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
WO2023086319A1 (en) | 2021-11-09 | 2023-05-19 | Ajax Therapeutics, Inc. | 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU701776B2 (en) * | 1994-05-27 | 1999-02-04 | Merck & Co., Inc. | Compounds for inhibiting osteoclast-mediated bone resorption |
WO1998008940A1 (en) | 1996-08-26 | 1998-03-05 | Novo Nordisk A/S | A novel endoglucanase |
JP2002511052A (ja) * | 1996-08-29 | 2002-04-09 | メルク エンド カンパニー インコーポレーテッド | インテグリンアンタゴニスト |
AU717283B2 (en) * | 1996-10-30 | 2000-03-23 | Merck & Co., Inc. | Integrin antagonists |
DE19653646A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung |
CA2277273C (en) * | 1997-01-17 | 2008-03-25 | Merck & Co., Inc. | Integrin antagonists |
EP0933367A1 (en) * | 1997-12-19 | 1999-08-04 | Hoechst Marion Roussel Deutschland GmbH | Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists |
HUP0100520A3 (en) * | 1998-01-23 | 2002-11-28 | Genentech Inc | Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
PA8474101A1 (es) * | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
US6365589B1 (en) * | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
EP1065207A1 (en) * | 1999-07-02 | 2001-01-03 | Aventis Pharma Deutschland GmbH | Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them |
DE10042655A1 (de) * | 2000-08-31 | 2002-03-14 | Aventis Pharma Gmbh | Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion |
JP2005526709A (ja) * | 2002-01-10 | 2005-09-08 | ニューロジェン・コーポレーション | メラニン凝集ホルモン受容体リガンド:置換ベンゾイミダゾールアナログ |
JP2008047614A (ja) | 2006-08-11 | 2008-02-28 | Showa Shell Sekiyu Kk | 吸着材を利用した改良型太陽電池モジュール |
-
1999
- 1999-07-02 EP EP99112636A patent/EP1065207A1/en not_active Withdrawn
-
2000
- 2000-06-26 TR TR2001/03856T patent/TR200103856T2/xx unknown
- 2000-06-26 YU YU92201A patent/YU92201A/sh unknown
- 2000-06-26 NZ NZ516058A patent/NZ516058A/xx unknown
- 2000-06-26 UA UA2002020852A patent/UA73133C2/uk unknown
- 2000-06-26 DK DK00945825T patent/DK1210348T3/da active
- 2000-06-26 IL IL14724800A patent/IL147248A0/xx unknown
- 2000-06-26 MX MXPA01013435A patent/MXPA01013435A/es active IP Right Grant
- 2000-06-26 BR BR0012129-0A patent/BR0012129A/pt not_active IP Right Cessation
- 2000-06-26 SK SK1913-2001A patent/SK19132001A3/sk unknown
- 2000-06-26 EP EP00945825A patent/EP1210348B9/en not_active Expired - Lifetime
- 2000-06-26 WO PCT/EP2000/005920 patent/WO2001002398A1/en not_active Application Discontinuation
- 2000-06-26 US US10/030,301 patent/US6743800B1/en not_active Expired - Fee Related
- 2000-06-26 EE EEP200100711A patent/EE200100711A/xx unknown
- 2000-06-26 KR KR1020017016961A patent/KR20020015996A/ko not_active Application Discontinuation
- 2000-06-26 AU AU59787/00A patent/AU775386B2/en not_active Ceased
- 2000-06-26 AT AT00945825T patent/ATE305471T1/de not_active IP Right Cessation
- 2000-06-26 PL PL00352280A patent/PL352280A1/xx not_active Application Discontinuation
- 2000-06-26 EA EA200200122A patent/EA004369B1/ru not_active IP Right Cessation
- 2000-06-26 JP JP2001507835A patent/JP2003503496A/ja not_active Withdrawn
- 2000-06-26 CN CNB008123365A patent/CN1160356C/zh not_active Expired - Fee Related
- 2000-06-26 DE DE60022890T patent/DE60022890T4/de not_active Expired - Lifetime
- 2000-06-26 ES ES00945825T patent/ES2250157T3/es not_active Expired - Lifetime
- 2000-06-26 HU HU0203539A patent/HUP0203539A3/hu unknown
- 2000-06-26 DE DE60022890A patent/DE60022890D1/de not_active Expired - Fee Related
- 2000-06-26 CZ CZ20014605A patent/CZ20014605A3/cs unknown
- 2000-06-26 CA CA002376668A patent/CA2376668C/en not_active Expired - Fee Related
- 2000-06-29 MY MYPI20002962 patent/MY133246A/en unknown
- 2000-06-29 AR ARP000103313A patent/AR024622A1/es active IP Right Grant
- 2000-09-01 TW TW089117925A patent/TW593319B/zh not_active IP Right Cessation
-
2001
- 2001-12-20 BG BG106257A patent/BG106257A/bg unknown
- 2001-12-21 HR HR20010946A patent/HRP20010946A2/hr not_active Application Discontinuation
- 2001-12-28 NO NO20016404A patent/NO20016404L/no not_active Application Discontinuation
-
2002
- 2002-01-02 ZA ZA200200016A patent/ZA200200016B/en unknown
-
2003
- 2003-03-25 HK HK03102163.4A patent/HK1050003B/zh not_active IP Right Cessation
-
2004
- 2004-03-24 US US10/808,496 patent/US20040198718A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1202965T3 (da) | Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse | |
NO20014013L (no) | 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem | |
NO20001409D0 (no) | Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger | |
EE200100684A (et) | Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
NO20024175D0 (no) | Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme | |
NO20020687L (no) | 3(5)-ureido-pyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler | |
NO20032733L (no) | Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse | |
DK1202733T3 (da) | 3(5)-amino-pyrazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler | |
NO20012567D0 (no) | Azepinoindolderivater, fremstilling og anvendelse derav | |
NO20016038L (no) | Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme | |
NO20032830L (no) | Tetrahydropyridinderivater, fremstilling derav og anvendelse som celleproliferasjonsinhibitorer | |
DK199900554A (da) | Paroxetinsalte, fremgangsmåde til fremstilling deraf, farmaceutiske præparater omfattende disse og anvendelser deraf | |
DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
NO20015659L (no) | Purinderivater, fremstillingsmetode og farmasöytiske preparater inneholdende disse | |
DK1558612T3 (da) | Imidazopyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
DK1043307T3 (da) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
NO20016247D0 (no) | Streptograminderivater, deres fremstilling og preparater inneholdende derivatene | |
NO20022022L (no) | N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
NO20016404D0 (no) | Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
NO20013878D0 (no) | (1-fenacy-3-fenyl-3-piperidylety1)piperidin-derivater, fremgangsmate for fremstilling derav og farmasoytiske preparaterinneholdende de samme | |
DK1215213T3 (da) | Bicylliske aminopyrazinonderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse | |
NO20013141D0 (no) | Arylalkanoylderivater, fremgangsmåte for fremstilling derav, deres anvendelse og farmasöytiske produkter inneholdende disse | |
DK1183241T3 (da) | Spiroimidazolidinderivater, deres præparation, deres anvendelse og farmaceutiske præparationer omfattende disse | |
NO20001782D0 (no) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
DK1256583T3 (da) | Pyrimidin-4-on-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |